龙七胃康片治疗慢性胃炎的效果及对胃肠激素、炎症指标的影响OA
Efficacy of Longqi Weikang Tablets in treating chronic gastritis and its impact on gastrointestinal hormones and inflammatory indicators
目的 探讨龙七胃康片治疗慢性胃炎的效果.方法 选取2024年4月至12月成都市中西医结合医院消化内科收治的88例慢性胃炎患者作为研究对象,按照随机数字表法分为对照组和观察组,每组44例.对照组采用常规四联疗法治疗,观察组在对照组基础上联合龙七胃康片治疗.比较两组患者的中医证候积分、胃肠激素[胃动素(MOT)、胃蛋白酶原Ⅰ(PGⅠ)、胃泌素(GAS)]、炎症指标[表皮生长因子(EGF)、白细胞介素-32(IL-32)、转化生长因子-β 1(TGF-β 1)、一氧化氮(NO)]、疗效及不良反应.结果 治疗后,观察组中医证候积分低于对照组,MOT、PG Ⅰ及GAS水平均高于对照组,EGF、IL-32及TGF-β 1水平均低于对照组,NO高于对照组,差异有统计学意义(P<0.05).观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05).两组患者的不良反应总发生率比较,差异无统计学意义(P>0.05).结论 慢性胃炎患者采用龙七胃康片治疗,胃脘痛、反酸等症状得到有效改善,炎症反应减轻,胃肠激素水平提高,治疗效果显著,且安全性较高,值得临床借鉴.
Objective To explore the efficacy of Longqi Weikang Tablets in treating chronic gastritis.Methods A total of 88 patients with chronic gastritis admitted to the Department of Gastroenterology of Chengdu Integrated TCM&Western Medicine Hospital from April to December 2024 were selected as the research subjects,they were divided into the control group and the observation group according to random number table method,with 44 cases in each group.The control group was treated with conventional quadruple therapy,while the observation group was treated with quadruple therapy combined with Longqi Weikang Tablets.The Chinese syndrome scores,gastrointestinal hormones(motilin[MOT],pepsinogen Ⅰ[PG Ⅰ],gastrin[GAS]),inflammatory indicators(epidermal growth factor[EGF],interleukin-32[IL-32],transforming growth factor-β1(TGF-β1),nitric oxide[NO]),therapeutic effect and adverse reactions were compared between the two groups.Results After treatment,the Chinese syndrome scores of the observation group were lower than those of the control group,while the levels of MOT,PG Ⅰ and GAS were higher than those of the control group,and the levels of EGF,IL-32 and TGF-β1 were lower than those of the control group,NO was higher than that of the control group,the differences were statisti-cally significant(P<0.05).The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).There was no statistically significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion For patients with chronic gastritis,treatment with Longqi Weikang Tablets can effectively alleviate symptoms such as epigastric pain and acid reflux,reduce inflammatory responses,increase gastrointestinal hormones levels.The therapeutic effect is remarkable,and have high safety.It is worthy of clinical reference.
付国川;潘涛;刘锐;徐欢;温旭东
成都市中西医结合医院消化内科,四川成都 610041成都市中西医结合医院消化内科,四川成都 610041成都市中西医结合医院消化内科,四川成都 610041成都市中西医结合医院消化内科,四川成都 610041成都市中西医结合医院消化内科,四川成都 610041
医药卫生
慢性胃炎四联疗法龙七胃康片疗效胃肠激素炎症指标安全性
Chronic gastritisQuadruple therapyLongqi Weikang TabletsTherapeutic efficacyGastrointestinal hor-monesInflammatory indicatorSafety
《中国当代医药》 2026 (24)
24-27,32,5
评论